The carriers of ofCS are syndecan 1 (SDC1) and chondroitin sulfate proteoglycan 4 (CSPG4), proteoglycans that are highly expressed in BC and thus increase the overall amount of ofCS in the tumor [216]. Here, SDC1 is linked to breast cancer.